Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 14, 2017; 23(10): 1872-1880
Published online Mar 14, 2017. doi: 10.3748/wjg.v23.i10.1872
Table 1 Clinical features and metastatic sites n (%)
FeaturesBone metastases
P valueLiver metastases
P valueLung metastases
P valueDistant lymph nodes
P valueBrain metastases
P value
YesNoYesNoYesNoYesNoYesNo
Age (yr)0.002< 0.00010.008< 0.00010.636
< 65396 (7.7)4724 (92.3)3996 (78.0)1124 (22.0)961 (18.8)4159 (81.2)569 (11.1)4551 (88.9)37 (0.7)5083 (99.3)
≥ 65514 (6.3)7599 (93.7)6092 (75.1)2021 (24.9)1677 (20.7)6463 (79.3)677 (8.3)7436 (91.7)53 (0.7)8060 (99.3)
Race0.0760.0010.3120.0590.314
White727 (9.6)9734 (93.1)7974 (76.2)2487 (23.8)2106 (20.1)8355 (79.9)1005 (9.6)9456 (90.4)71 (0.7)10390 (99.3)
Black105 (5.9)1661 (94.1)1388 (78.6)378 (21.4)329 (18.6)1437 (81.4)140 (7.9)1626 (92.1)16 (0.9)1750 (99.1)
Others928 (93)78 (7.0)726 (73.0)280 (27.0)203 (19.0)803 (81.0)905 (90.0)101 (10.0)3 (0.2)1003 (99.8)
Gender0.002< 0.00010.0200.0280.770
Male636 (7.5)6613 (92.5)5565 (77.8)1584 (22.2)1372 (19.2)5777 (80.8)710 (9.9)6439 (90.1)50 (0.7)7099 (99.3)
Female374 (6.1)5710 (93.9)4523 (74.3)1561 (25.7)1266 (20.8)4818 (79.2)536 (8.8)5548 (91.2)40 (0.7)6044 (99.3)
Location of the primary0.0010.084< 0.00010.0030.024
Head269 (5.8)4387 (94.2)3580 (76.9)1076 (23.1)828 (17.2)3828 (82.2)480 (10.3)4176 (89.7)21 (0.5)4635 (99.5)
Body/tail340 (7.2)4408 (92.8)3638 (76.6)1110 (23.4)961 (20.2)3787 (79.8)394 (8.3)4354 (91.7)33 (0.7)4715 (99.3)
Unknown301 (7.9)3528 (92.1)2870 (75.0)959 (25.0)849 (22.2)2980 (77.8)372 (9.7)3457 (90.3)36 (0.9)3793 (99.1)
Marital status0.0830.8950.0830.0140.189
Married512 (7.1)6720 (92.9)5510 (76.2)1722 (23.8)1402 (19.4)5830 (80.6)722 (10.0)6510 (90.0)43 (0.6)7189 (99.4)
Unmarried398 (6.6)5603 (93.4)4578 (76.3)1423 (23.7)1236 (20.6)4765 (79.4)524 (8.7)5477 (91.3)47 (0.8)5954 (99.2)
T stage< 0.0001< 0.00010.003< 0.0001< 0.0001
T129 (8.9)296 (91.1)242 (74.5)83 (25.5)59 (18.2)266 (81.8)23 (7.1)302 (92.9)3 (0.9)322 (99.1)
T2209 (6.7)3079 (93.6)2705 (82.3)583 (17.7)595 (18.1)2693 (81.9)277 (8.4)3011 (91.6)17 (0.5)3271 (99.5)
T3200 (5.5)3460 (94.5)2699 (73.7)961 (26.3)711 (19.4)2949 (80.6)345 (9.4)3315 (90.6)11 (0.3)3649 (99.7)
T4153 (6.8)2106 (93.2)1611 (71.3)648 (28.7)504 (22.3)1755 (77.7)278 (12.3)1981 (87.7)13 (0.6)2246 (99.4)
Tx319 (9.0)3382 (91.0)2831 (76.0)870 (24.0)769 (20.5)2932 (79.5)323 (10.0)3378 (90.0)46 (1.2)3655 (98.8)
N stage< 0.00010.788< 0.0001< 0.00010.089
N0395 (5.8)6424 (94.2)5210 (76.4)1609 (23.6)1143 (16.8)5676 (83.2)310 (4.5)6509 (95.5)36 (0.5)6783 (99.5)
N1354 (8.7)3729 (91.3)3097 (75.9)986 (24.1)1018 (24.9)3065 (75.1)811 (19.9)3272 (80.1)34 (0.8)4049 (99.2)
Nx161 (6.9)2170 (93.1)1781 (76.4)550 (23.6)477 (20.5)1854 (79.5)125 (5.4)2206 (94.5)20 (0.9)2311 (99.1)
Surgery of the primary0.035< 0.00010.0060.2650.422
Yes7 (3.1)218 (96.9)112 (49.8)113 (50.2)26 (11.6)199 (88.4)15 (6.7)210 (93.3)0 (0)225 (100.0)
No903 (7.0)12105 (93.0)9976 (76.7)3033 (23.3)2612 (20.1)10369 (79.9)1231 (9.5)11777 (90.5)90 (0.7)12918 (99.3)
Surgery of the metastases0.808< 0.00010.002< 0.00010.503
Yes38 (6.6)534 (93.4)288 (50.3)284 (49.7)81 (14.2)491 (85.8)91 (15.9)481 (84.1)6 (1.0)566 (99.0)
No872 (6.7)11789 (93.3)9800 (77.4)2861 (22.6)2557 (20.2)10104 (79.8)1155 (9.1)11506 (90.9)84 (0.7)12577 (99.3)
Table 2 Multivariate analyses of overall survival and pancreatic cancer-specific survival in metastatic pancreatic cancer patients
FeaturesOverall survival
Pancreatic cancer-specific survival
Hazard ratio(95%CI)P valueHazard ratio (95%CI)P value
Age (yr)
< 651.00 (reference)1.00 (reference)
> 651.343 (1.292-1.396)< 0.00011.131 (1.083-1.181)< 0.0001
Race
Black1.00 (reference)1.00 (reference)
White0.913 (0.865-0.965)0.0010.924 (0.869-0.983)0.013
Others0.891 (0.818-0.971)0.0090.956 (0.870-1.052)0.360
Gender
Female1.00 (reference)1.00 (reference)
Male1.117 (1.075-1.160)< 0.00011.087 (1.042-1.135)< 0.0001
Marital status
Married1.00 (reference)1.00 (reference)
Unmarried1.243 (1.196-1.291)< 0.00011.222 (1.170-1.276)< 0.0001
T stage
T11.00 (reference)1.00 (reference)
T21.151 (1.015-1.304)0.0281.170 (1.015-1.349)0.030
T31.014 (0.895-1.149)0.8261.033 (0.896-1.191)0.652
T40.974 (0.857-1.107)0.6880.986 (0.853-1.141)0.851
N stage
N01.00 (reference)1.00 (reference)
N11.004 (0.962-1.049)0.8411.001 (0.954-1.051)0.958
Surgery of the primary
No1.00 (reference)1.00 (reference)
Yes0.573 (0.489-0.671)< 0.00010.537 (0.448-0.643)< 0.0001
Surgery of the metastases
No1.00 (reference)1.00 (reference)
Yes0.773 (0.703-0.851)< 0.00010.782 (0.703-0.871)< 0.0001
Distant metastases
Multiple metastases1.00 (reference)1.00 (reference)
Single metastasis1.080 (0.900-1.297)0.4091.049 (0.867-1.270)0.619